Expiration of COVID Test Reimbursement Mandate Means Prices Will Fall, Experts Say

Starting May 11, payers will no longer have to cover any COVID-19 polymerase chain reaction (PCR) testing with no cost sharing for members, or reimburse members who purchase over-the-counter COVID tests. It’s one of many health care policy changes dictated by the planned end of the federal COVID public health emergency (PHE) on that date. Experts tell AIS Health, a division of MMIT, that the transition will likely cause PCR test prices to fall.

The Families First Coronavirus Response Act and the CARES Act, both passed in 2020, require private health insurers to cover coronavirus tests, with no cost sharing, as well as any services associated with those tests (such as administrative fees), per an expansive reading of both laws implemented by the Biden administration starting in 2021. During 2020, the incumbent Trump administration had required coverage only for “medically necessary” tests ordered by a practitioner. In addition, the Biden administration starting in January 2022 required health plans to reimburse members for up to eight at-home tests per month.

© 2024 MMIT
Peter Johnson

Peter Johnson

Peter has been a reporter for nearly a decade. Before joining AIS Health, Peter covered a wide variety of topics in his hometown of Seattle, where he continues to live. Peter’s work has appeared in publications including The Atlantic and The Stranger. Peter attended Colby College.

Related Posts

February 3

Some Insurers Balk, but Analysts Are Not Overly Concerned by Medicaid Block Grant Guidance

Read More
February 12

Feds Launch Testing Strategy, but Price Gouging Continues

Read More


Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today